Plerixafor

Nat Rev Drug Discov. 2009 Feb;8(2):105-6. doi: 10.1038/nrd2819.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Benzylamines
  • Cyclams
  • Drug Approval
  • Drug Therapy, Combination
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Hematopoietic Stem Cell Transplantation*
  • Heterocyclic Compounds / adverse effects
  • Heterocyclic Compounds / pharmacology*
  • Heterocyclic Compounds / therapeutic use*
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / therapy
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / therapy
  • Randomized Controlled Trials as Topic
  • Receptors, CXCR4 / antagonists & inhibitors*

Substances

  • Benzylamines
  • Cyclams
  • Heterocyclic Compounds
  • Receptors, CXCR4
  • Granulocyte Colony-Stimulating Factor
  • plerixafor